[Ip-health] 2 new opposition on sofosbuvir patent at the EPO

Céline Grillon celine.grillon at medecinsdumonde.net
Mon Feb 23 01:12:47 PST 2015


Dear all,

3 more oppositions have been filed : one by Teva, one by Mylan and one by Pharmaceutical Works PolPharma (API Manufacturer from Poland). 
Regards,

Céline Grillon
Harm Reduction, HCV & HIV
Advocacy Officer /Chargée de plaidoyer
Réduction des Risques, VHC et VIH
celine.grillon at medecinsdumonde.net<mailto:celine.grillon at medecinsdumonde.net>

Médecins du Monde
62 rue Marcadet 75018 PARIS
t. + 33 (0) 1 44 92 13 02
m: + 33 (0) 6 50 01 39 10
www.hepCoalition.org<http://www.hepcoalition.org/>

-----Message d'origine-----
De : Ip-health [mailto:ip-health-bounces at lists.keionline.org] De la part de Céline Grillon
Envoyé : vendredi 20 février 2015 17:45
À : Ip-health at lists.keionline.org
Objet : [Ip-health] 2 new opposition on sofosbuvir patent at the EPO

Dear all,

Two other oppositions have been filed against sofosbuvir patent at the European Patent Office. You can have look through this link : https://register.epo.org/application?number=EP08732818&lng=en&tab=doclist

It is interesting to note that the two oppositions are anonymous, as they have been filed in the name of the attorneys in charge of the opposition and not in the name of the true opponents (perhaps pharmaceutical companies which do not wish to support arguments which could be returned against their own patents). The arguments are quite in line with our own arguments.

Regards,
Céline Grillon
Harm Reduction, HCV & HIV
Advocacy Officer /Chargée de plaidoyer
Réduction des Risques, VHC et VIH
celine.grillon at medecinsdumonde.net<mailto:celine.grillon at medecinsdumonde.net>

Médecins du Monde
62 rue Marcadet 75018 PARIS
t. + 33 (0) 1 44 92 13 02
m: + 33 (0) 6 50 01 39 10
www.hepCoalition.org<http://www.hepcoalition.org/>

_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org




More information about the Ip-health mailing list